TocilizumabV1, Main, Exploration, bibRecord, 000D19

Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis.

Identifieur interne : 000D19 ( Main/Exploration ); précédent : 000D18; suivant : 000D20

Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis.

Auteurs : Young Ho Lee [Corée du Sud] ; Gwan Gyu Song [Corée du Sud]

Source :

Annals of the rheumatic diseases [ 1468-2060 ] ; 2019.

RBID : pubmed:29288209

Descripteurs français

KwdFr :
- Anticorps monoclonaux humanisés, Artérite à cellules géantes, Humains, Japon, Maladie de Takayashu, Méthode en double aveugle.
MESH :
- Anticorps monoclonaux humanisés, Artérite à cellules géantes, Humains, Japon, Maladie de Takayashu, Méthode en double aveugle.
Wicri :
- geographic : Japon.

English descriptors

KwdEn :
- Antibodies, Monoclonal, Humanized, Double-Blind Method, Giant Cell Arteritis, Humans, Japan, Takayasu Arteritis.
MESH :
- chemical : Antibodies, Monoclonal, Humanized.
- geographic : Japan.
- Double-Blind Method, Giant Cell Arteritis, Humans, Takayasu Arteritis.

DOI: 10.1136/annrheumdis-2017-212838
PubMed: 29288209

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis.</title>
<author><name sortKey="Lee, Young Ho" sort="Lee, Young Ho" uniqKey="Lee Y" first="Young Ho" last="Lee">Young Ho Lee</name>
<affiliation wicri:level="3"><nlm:affiliation>Division of Rheumatology, Korea University Medical Center, Seoul, South Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Division of Rheumatology, Korea University Medical Center, Seoul</wicri:regionArea>
<placeName><settlement type="city">Séoul</settlement>
<region type="capital">Région capitale de Séoul</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Song, Gwan Gyu" sort="Song, Gwan Gyu" uniqKey="Song G" first="Gwan Gyu" last="Song">Gwan Gyu Song</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, College of Medicine, Korea University, Seoul, South Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Rheumatology, College of Medicine, Korea University, Seoul</wicri:regionArea>
<placeName><settlement type="city">Séoul</settlement>
<region type="capital">Région capitale de Séoul</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:29288209</idno>
<idno type="pmid">29288209</idno>
<idno type="doi">10.1136/annrheumdis-2017-212838</idno>
<idno type="wicri:Area/PubMed/Corpus">000899</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000899</idno>
<idno type="wicri:Area/PubMed/Curation">000899</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000899</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000485</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000485</idno>
<idno type="wicri:Area/Ncbi/Merge">001882</idno>
<idno type="wicri:Area/Ncbi/Curation">001882</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001882</idno>
<idno type="wicri:Area/Main/Merge">000D19</idno>
<idno type="wicri:Area/Main/Curation">000D19</idno>
<idno type="wicri:Area/Main/Exploration">000D19</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis.</title>
<author><name sortKey="Lee, Young Ho" sort="Lee, Young Ho" uniqKey="Lee Y" first="Young Ho" last="Lee">Young Ho Lee</name>
<affiliation wicri:level="3"><nlm:affiliation>Division of Rheumatology, Korea University Medical Center, Seoul, South Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Division of Rheumatology, Korea University Medical Center, Seoul</wicri:regionArea>
<placeName><settlement type="city">Séoul</settlement>
<region type="capital">Région capitale de Séoul</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Song, Gwan Gyu" sort="Song, Gwan Gyu" uniqKey="Song G" first="Gwan Gyu" last="Song">Gwan Gyu Song</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, College of Medicine, Korea University, Seoul, South Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Rheumatology, College of Medicine, Korea University, Seoul</wicri:regionArea>
<placeName><settlement type="city">Séoul</settlement>
<region type="capital">Région capitale de Séoul</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of the rheumatic diseases</title>
<idno type="eISSN">1468-2060</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term>
<term>Double-Blind Method</term>
<term>Giant Cell Arteritis</term>
<term>Humans</term>
<term>Japan</term>
<term>Takayasu Arteritis</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps monoclonaux humanisés</term>
<term>Artérite à cellules géantes</term>
<term>Humains</term>
<term>Japon</term>
<term>Maladie de Takayashu</term>
<term>Méthode en double aveugle</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Japan</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Double-Blind Method</term>
<term>Giant Cell Arteritis</term>
<term>Humans</term>
<term>Takayasu Arteritis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Anticorps monoclonaux humanisés</term>
<term>Artérite à cellules géantes</term>
<term>Humains</term>
<term>Japon</term>
<term>Maladie de Takayashu</term>
<term>Méthode en double aveugle</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Japon</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Corée du Sud</li>
</country>
<region><li>Région capitale de Séoul</li>
</region>
<settlement><li>Séoul</li>
</settlement>
</list>
<tree><country name="Corée du Sud"><region name="Région capitale de Séoul"><name sortKey="Lee, Young Ho" sort="Lee, Young Ho" uniqKey="Lee Y" first="Young Ho" last="Lee">Young Ho Lee</name>
</region>
<name sortKey="Song, Gwan Gyu" sort="Song, Gwan Gyu" uniqKey="Song G" first="Gwan Gyu" last="Song">Gwan Gyu Song</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D19 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D19 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29288209
   |texte=   Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29288209" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a TocilizumabV1

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021

Serveur d'exploration Tocilizumab

Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis.

Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration Tocilizumab
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.